7American Diabetes Association. Clinical practice recommendations. Diabetes Care,2001, 24(Suppl.1): 5-24.
8World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, Part 1: Diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999.
9Mastrototaro J. The MiniMed continuous glucose monitoring system(CGMS). J Pediatr Endocriol Metab, 1999,12:751-758.
10Gross TM, Bode BW, Einhorn D, et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther,2000,2:49-56.
2Heise T, Heinemann L, Hovelmann U, et al. Biphasic insulin as-part 30/70: pharmacokinetics and pharmacodynamics compared with once-daily biphasic human insulin and Basal-bolus therapy[J]. Diabetes Care,2009,32(8):1431-1433.
3Jacobsen LV, Sogaard B, Riis A. Pharmacokinetics and pharmacodynamics of a pmmixed formulation of soluble and protaminemtarded insulin aspar[J]. Eur J Clin Pharmacol,2000,56(5):399-403.
